CM Life Sciences II Inc.
Status: Closed Deal
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Feb 23, 2021 |
| CEO | Eli D. Casdin |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | SomaLogic |
| Deal Announced | Mar 29, 2021 |
| Deal Size, $M | $1,230.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Aug 31, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 1, 2021 |
Formerly CMII
SLGC
SLGCW
| Price | 2.08 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.